Colorado Governor Jared Polis (D) signed a bill into law this month that would require the state’s prescription drug affordability board (PDAB) to consider input from the Colorado rare disease advisory council in determining which drugs are unaffordable for patients in the state and in setting potential payment limits. The new state law comes after a pared- back version of a bill would have nixed the board from considering orphan drugs all together. After the PDAB ruled Vertex’s Trikafta --...